The Venture Codex Logo

The Venture Codex

Overview

Innovative gene therapy development with precision delivery.

Total Raised

$97 M

Rounds

2

Links

Verticals

Biopharma
Biotechnology
Genetics
Therapeutics

Investment History

  1. Series A

    May 2026

    $43M

  2. Series A

    May 2024

    $54M

Team

Paiman Peter Ghoroghchian

Chief Executive Officer

Beverly Davidson

Founder

Jang-Ho Cha

Chief Scientific Officer and Chief Marketing Officer

John Connelly

Chief Development Officer